Content |
Assets
History
2022: Purchase of medical implant manufacturer for cartilage treatment CartiHeal
On April 4, 2022, Bioventus announced the purchase of a private company for the production of medical equipment in the form of implants for the treatment of cartilage CartiHeal for $450 million. The transaction is expected to close in the second quarter of 2022 subject to certain normal closing conditions. Bioventus plans a limited release of CartiHeal products to the US market in the third quarter of 2022. More details here.
2021: Purchase of surgical ultrasound instrument manufacturer Misonix for $518 million
In early August 2021, it was announced the sale of the manufacturer of surgical ultrasound tools Misonix for $518 million. It is bought by Bioventus, which entered into a deal after entering the exchange and acquiring another manufacturer of medical equipment Bioness for $110 million. More details here.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |